Get the latest news about CAVΛDIS™. You can view our press releases and relevant publications by following the appropriate links.
26 mei 2009, Utrecht (the Netherlands)
- Cavadis announced today the successful completion of its Series A financing round. Cavadis, a biomedical company active in the field of atherosclerosis, develops and exploits a portfolio of cardiovascular biomarkers.Read more
28 april 2009, Brussels (Belgium)
- Europe Unlimited today announced that Cavadis was named as one of the 50 best life sciences companies to present at the Benelux Venture Forum 50, held on 28 May 2009 in Ghent